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Introduction: Cervical cancer is the third most incident and the fourth most lethal
cancer among Costa Rican women. The purpose of this study was to quantify incidence
inequality along three decades and to explore its determinants.
Materials and Methods: This is a population-based study. Main data sources
were the National Tumor Registry (1980–2010), CRELES (Costa Rican Longevity and
Healthy Aging Study) longitudinal survey (2013), and published indices of economic
condition (2007) and access to healthcare (2000). Cartography was made with QGIS
software. Inequality was quantified using the Theil-T index. With the purpose of
detecting differences by tumor’s behavior, inequality was estimated for “in situ” and
invasive incidence. In Situ/Invasive Ratios were estimated as an additional marker of
inequality. Poisson and spatial regression analyses were conducted with Stata and
ArcMap software, respectively, to assess the association between incidence and social
determinants such as economic condition, access to healthcare and sub-utilization of
Papanicolaou screening.
Results: As measured by Theil-T index, incidence inequality has reached high (83 to
87%) levels during the last three decades. For invasive cervical cancer, inequality has
been rising especially in women aged 50–59; increasing from 58% in the 1980’s to 66%
in 2000’s. Poisson regression models showed that sub-utilization of Papanicolaou smear
was associated with a significant decrease in the probability of early diagnosis. Costa
Rican guidelines establish a Pap smear every 2 years; having a Pap smear every 3 years
or longer was associated with a 36% decrease in the probability of early “in situ” diagnosis
(IRR = 0.64, p = 0.003) in the last decade. Spatial regression models allowed for the
detection of specific areas where incidence of invasive cervical cancer was higher than
expected.
Conclusion: Results from this study provide evidence of inequality in the incidence
of cervical cancer, which has been high over three decades, and may be explained
by sub-utilization of Papanicolaou smear screening in certain regions. The reasons
why women do not adequately use screening must be addressed in future research.
Interventions should be developed to stimulate the utilization of screening especially
among women aged 50 to 59 where inequality has been rising.
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INTRODUCTION
In 2005, the World Health Organization (WHO) created the
Commission on Social Determinants of Health with the purpose
of helping nations to face the social causes of health and reduce
inequity (1). An explanatory model of the way by which health
status is produced or affected within a population points to
four categories of determinants: biological, environmental,
health-service related and socio-economic as well as
cultural (2).
The nature and the magnitude of inequality on health
outcomes need to be investigated. On one hand, the nature refers
to the origin of each situation; it allows to better understand
the ways in which differences developed. On the other hand,
assessing the magnitude may be associated with the impact
this situation has on a population. Quantifications of inequality
are used in the current study and further discussed under the
framework of the social determinants of health to examine the
incidence of cervical cancer as a health outcome.
Cervical cancer is the third most incident malignant
tumor among Costa Rican females, with a rate of 30
cases per 100,000 women in 2015. This incidence is only
surpassed by skin and breast cancer with rates of 61 and
60 cases per 100,000 women, respectively (3). It is the
fourth most important cause of malignant cancer mortality
among the female population with a rate of 6 deaths
per 100,000 women in 2016. Cervical cancer mortality
is only surpassed by breast, stomach, and colon cancer
(4).
In Costa Rica, like in other countries, an association between
cervical cancer incidence and geographic location has been
previously described. Using data from the National Tumor
Registry for the period 1980 to 1983, [Sierra and Barrantes (5)]
found a higher incidence of cervical cancer in the coastal vs.
non-coastal areas. Further, the Ministry Health (3) documented
higher prevalences of cervical cancer in coastal regions. The
geographical distribution of incidence shows that Costa Rican
women are not affected in a homogeneous manner within the
country.
The human papilloma virus (HPV) is the most important
risk factor for the development of cervical cancer (6). The 2015
Costa Rican National Survey on Reproductive and Sexual Health
indicates that in the country only 45% of women and 44%
of men recognize the HPV as a sexually transmitted infection
(7). Sexual behavior is an important risk factor for cervical
cancer and socioeconomic status has been associated with sexual
behaviors that favor the acquisition of HPV. [De Sanjosé and
collaborators (8)], in two case-control studies carried out in
Colombia and Spain, determined that human papilloma virus
was more frequent in women of low vs. high socio-economic
status. Moreover, another study confirmed the association
between socioeconomic status and HPV for different cancer sites,
including cervical cancer (9). However, higher prevalence of HPV
in middle and high socio-economic status in Latin America
and in developed countries, may evidence that socioeconomic
differences in incidence result from access to screening inequality
rather than HPV prevalence inequality. Sancho-Garnier et al.
(10), make a case of how high income countries with established
preventive programs have persistent inequalities in detection
because of inequality in access to screening programs.
Starting in the 1960s and up to the 1980s, cervical cancer
cases were primarily detected via population-based screening
programs such as Papanicolaou smear, a conventional cytology
that tests for the presence of precancerous or cancerous cells on
the cervix. More recently, screening by human papillomavirus
(HPV) testing has been established as more accurate and
effective. Although HPV testing is expected to become the
preferred screening test in the medium and long term (11),
Pap smear is still the recommended screening procedure in
healthcare protocols in Costa Rica. Timely access to screening
services allows early detection of malignant tumors. In general,
low-income women show higher rates of cancer detection at
advanced stages (12). It is therefore frequently assumed that
inequality in cervical cancer incidence in diverse populations
may be the result of unequal access to screening services. If this
were indeed the case, it would be expected that a public policy
to improve access to screening would lead to a reduction of
inequality (13).
In an exploratory analysis using geographic information
systems and data from the National Tumor Registry between
1990 and 1997, [Santamaría (14)] reported a significantly higher
incidence of cervical cancer in southern and Caribbean regions of
the country, primarily in the provinces of Puntarenas and Limon,
where the relative risk of invasive cervical cancer reached values
that were 2.1 times higher than in the rest of the country. These
regions have the lowest indices of human and social development
in Costa Rica.
There is evidence that cervical cancer affects Costa Rican
women in a heterogeneous manner; and it is also evident that
this phenomenon has persisted for several decades in the country.
Nevertheless, neither the magnitude of this existing inequality
has been quantified, nor has the research on inequality been
approached from the perspective of the social determinants of
health. The aim of this study is to determine the magnitude of
the disparities in cervical cancer incidence within Costa Rica and
to identify factors associated with incidence, in order to inform
policies to reduce disparities.
METHODS
This study was conducted after obtaining approval from the
Scientific Ethics Committee at the University of Costa Rica (VI-
3621-2012). This is a population-based study, geographic units
rather than individuals are its units of analysis. Costa Rica has
an area of 51,100 km², administratively divided into 7 provinces.
In 2018, a total of 82 counties and 484 districts were contained
within those provinces. Cervical cancer incidence was analyzed
both at the county and the district level for a 31-year time period:
1980 to 2010.
Analyses were conducted for total, in situ, and invasive
cervical cancer incidence. Most of analyses were broken
down into 3 periods: 1980–1989, 1990–1999, and 2000–2010.
Regression models were estimated for the last period: 2000–2010.
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Data Description
Five sources of information were used: (1) Cancer cases
from National Tumor Registry, (2) Population exposed from
Official Population Estimations, (3) Population economic
condition from the Social Development Index, (4) Population
access to healthcare from a geographical access to healthcare
index, and (5) Papanicolaou sub-utilization from the
survey CRELES: Costa Rican Longevity and Healthy Aging
Study.
Cancer cases come from the National Tumor Registry (NTR)
database from 1980 to 2010. Access to the NTR was provided
by the Costa Rican Ministry of Health. The standard NTR
record contains age, calendar year, and place of residence at
diagnosis. A count of cases for each geographical unit was
made for each of the time periods of interest. This nationwide
population-based registry has been maintained by the Ministry
of Health since 1977. Since 1980 all hospitals and private
pathologists have agreed to report any hospitalizations or
outpatient biopsies associated with a cancer diagnosis (15). This
registry has high indices of data quality (16) and since the
1980s this NTR’s coverage has been estimated to be around
98% (17).
Population exposed from 1980 to 2010 within each
geographical unit was estimated based on the official updated
estimation figures for female population. These estimations
are jointly elaborated by the National Institute for Population
Statistics and Census and the Central American Population
Center of the University of Costa Rica (18).
Using data from the NTR on newly diagnosed cases of cervical
cancer as well as the official population estimations, we estimated
cervical cancer incidence rates. Data from the NTR constitutes
the numerator of the cervical cancer incidence rate for each
geographic unit. The denominator of the rate is the female
population at mid-period, multiplied by the number of years
included in the numerator, in order to estimate annualized rates.
Because age distribution in this population was not significantly
different from Segi’s world standard population (chi = 128, p =
0.292), crude incidence rates per 100,000 women were estimated
for this study. QGIS software (19) was used to represent incidence
rates in maps.
The following three data sources were used in regression
models to explain incidence for the 2000–2010 period.
Because of availability of data, they belong to different
years, which are the closest possible to the 2000–2010
period.
Data on economic condition in 2007 is the official estimation
of the Social Development Index’ economic component, which is
estimated by the Costa RicanMinistry of Planning. The economic
dimension of the index is a compound measure of residential
electricity consumption and residential access to Internet. It
captures population capability of acquiring goods and services,
and population’s technology access (20).
Access to healthcare in 2000 is measured as a comprehensive
index of geographic accessibility to healthcare facilities in
Costa Rica. All healthcare facilities are included in this index:
primary healthcare facilities, clinics and hospitals. It was created
using Geographic Information System (GIS) technologies and
aggregating characteristics of both population and healthcare
facilities (21).
Sub-utilization of Papanicolaou screening in 2013 is estimated
from the survey CRELES: Costa Rican Longevity and Healthy
Aging Study. Data from this longitudinal survey is publicly
available (22).
Statistical Analyses
The Theil T index (23) was used to quantify inequality at a
district level. Incidence rates were the basis for the quantitative
estimation of inequality in the distribution of this pathology. This
index has been widely used to measure inequality in different
health and social outcomes. It has for example been used to
measure income inequality in Latin America (24) or inequality
in access to improved water in different world regions (25).
This indicator was selected because it can estimate inequality
even when geographical units have a null incidence rate. Having
a number of geographical units with no cases is an expected
scenario given the small size of the unit of analysis (district) and
the fact that the event is considered to be infrequent. Theil-T is a
population weighted index that is sensitive to health differences
further from the average rate (26).
The Theil-T index is defined as follows:
T =
N∑
u=1
yu log
yu
1
N
(1)
Where:
For each u = 1,2,. . . , geographical units (districts)
yu = number of cases of cervical cancer diagnosed in district u
N = female population size.
Carcinoma in situ/Invasive Cervical Cancer Ratios (CIS/ICC)
were estimated as an additional marker of inequality. A CIS/ICC
= 1 means that for each carcinoma in situ, there is another
invasive cervical cancer detected. Ideally the incidence of
carcinoma in situ should exceed that of invasive cancer (CIS/ICC
> 1), indicating amajority of cases being detected at an early stage
(27). CIS/ICC were represented in maps using QGIS software
(19).
Multivariate regression analyses were also carried out at the
district level in the 2000–2010 period. Poisson and geographically
weighted spatial regression models were estimated with Stata
(28) and ArcMap (29) software respectively, to assess the
association between incidence and social determinants such as
economic condition, access to healthcare and sub-utilization
of Papanicolaou smear. Cervical cancer counts and incidence
rates were the dependent variable of Poisson and spatial
regression models, respectively. The social determinants of this
health outcome (economic condition, access to healthcare, and
sub-utilization of Papanicolaou smear) were controlled for as
independent variables in both types of models.
Because cervical cancer is an infrequent event, cases are
assumed to be generated from a Poisson distribution. Poisson
is adequate to model cases of infrequent illnesses with a small
number of cases (30). When the dependent variable is a counting
(number of new cervical cancer cases on each district), that takes
the form of entire non-negative values, a Poisson specification is
Frontiers in Oncology | www.frontiersin.org 3 January 2019 | Volume 8 | Article 664
Santamaría-Ulloa and Valverde-Manzanares Inequality in Cervical Cancer
an improvement over Ordinary Least Squares (31). The Poisson
distribution provides the probability of the number of events;
and the parameters correspond to the expected number of
occurrences as a function of the independent variables (32). This
model was estimated using Stata software (28).
Using the count of cases as the dependent variable in Poisson
regression models, suggests the need to control for female
population exposed to cervical cancer in each district, because
each count of cases refers to areas of different underlying
populations. The observed number of cases bi was the dependent
variable, and the expected number of cases bEi was the offset
variable introduced in the right hand side of the model. The
Poisson regression model is defined as follows:
bi = P(bi, x) (2)
bEi =
∑
(Mix
∗WSi x) (3)
Where:
bi is the observed number of cases at location i;
P indicates a Poisson function;
x is the age group;
bEi is the expected number of cases at location i;
Mi x is the observed population size in location i at age x; and
WSi x is the incidence rate in the standard population at age x.
A geographically weighted regression was also carried out.
This spatial regression tool is based on mathematical models
that take into account spatial auto-correlation and it has been
previously used in cancer research conducted in Costa Rica
(33). Counties close to each other have a greater probability of
sharing characteristics among themselves due to their geographic
proximity than those that are located more distantly from one
another, which makes this methodology relevant for the current
study. This model was estimated using the GWR (Geographically
Weighted Regression) tool in ArcMap software (29) and maps
were made using QGIS software (19).
Parameters in a global regression model are very likely
not constant across space, and geographically weighted
regressions allow determining how each parameter varies across
a geographical area. This statistical tool helps understand spatial
heterogeneity in data (33), which justifies its use in this study.
Social determinants were used as independent variables
in both the Poisson and the spatial regression model. The
Costa Rican Ministry of Health (34), following Lalonde
(2), classifies social determinants into four categories: (1)
biological determinants; (2) environmental determinants; (3)
socioeconomic as well as cultural determinants; and (4)
determinants related to the healthcare services. Controlling for
all four categories of determinants in regression models would
be optimal. Nevertheless, at the population level there is no
information regarding the first category of biological factors
such as the population prevalence of human papilloma virus
(HPV). There is also no data available on the second category of
environmental factors that may be associated with the incidence
of cervical cancer such as tobacco smoking (35).
Although for the purpose of this study it is not possible to
explore the association between cervical cancer and biological
and environmental factors, the third and fourth categories
of determinants—socioeconomic and healthcare—have been
included in the analyses.
Regarding the third category of socioeconomic determinants,
it is desirable to consider several dimensions of socioeconomic
status (36). The economics dimension of the social development
index (SDI) was used in this study as a measure of economic
condition at the district level (20). This approach of quantifying
socioeconomic determinants is similar to the one used in a
previous research (37).
Regarding the fourth category of determinants related to the
healthcare services, density index of access to healthcare services
and sub-utilization of Papanicolaou smear were included.
Although access to healthcare is a concept with at least two
dimensions: geographic and social (38), geographic access is what
this index measures. Geographical access to healthcare facilities
in 2,000 is measured using a comprehensive index of accessibility
that results from the aggregation of all facilities weighted by their
size, proximity, and characteristics of both the population and
the facility. The density index of access to healthcare services
uses physician hours per capita yearly as the metric. The greater
the value a district has for this index, the better access to health
services has its population. Greater details on the construction of
this index can be found in Rosero-Bixby (21).
Sub-utilization of Papanicolaou screening in 2013 was
obtained from CRELES: Costa Rica Study of Longevity and
Healthy Aging. Rates are based on a question about when was
the last time women had a Papanicolaou screening. According
to national attention guidelines, Papanicolaou screening should
be conducted at least every 2 years (39). A measure of the
proportion of female population who had their last screening
3 years ago or longer is used as an indicator of sub-utilization
of Pap smear in this study. Because of sampling issues, it was
not possible to obtain district level estimations; therefore the
indicator was estimated for counties, which are larger geographic
units.
RESULTS
A total of 22,279 incident cases of cervical cancer occurred in
Costa Rica during the 1980–2010 time period. Because this study
is based on geographical units, 5.4% of cases were not included
on the grounds of not containing any information about patient’s
place of living at diagnosis.
A total of 21,075 cases were included in the analyses. In
absence of information, district or county imputation was
conducted in 7.0% of cases (5.3% of cases with no district
information and 1.7% of cases with no county information).
Imputation was made under of the assumption that missing
information followed the distribution of non-missing cases
within its corresponding county or province.
Cases were distributed along the period of study as follows:
26% during 1980–1989, 31% in 1990–1999, and 42% in 2000–
2010. The number of cases had a 79% increase from the
1980s to the 2000s, which is mainly attributed to an increase
in the detection of carcinoma in situ. Details on numerators,
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TABLE 1 | Descriptive data on cervical cancer incidence, by time period. Costa Rica: 1980–2010.
Indicator 1980–1989 1990–1999 2000–2010 Total
CERVICAL CANCER CASES
Excluded from analyses
No geographical location available 595 47 562 1.204
Included in analyses
In situ 2,998 3,421 6,202 12,621
Invasive 2,239 2,559 3,656 8,454
Total cases included in analyses 5,237 5,980 9,858 21,075
Total cases reported in NTR 5,832 6,027 10,420 22,279
POPULATION EXPOSED
Female population at mid-period 1,281,313 1,671,216 2,065,853 1,671,216
CERVICAL CANCER ANNUALIZED INCIDENCE RATE PER 100,000 WOMEN
In situ 23.40 20.47 27.29 24.36
Invasive 17.47 15.31 16.09 16.32
Total 40.87 35.78 43.38 40.68
In situ/Invasive Incidence Rate Ratio 1.34 1.34 1.70 1.46
denominators, incidence rates, and ratios by period are included
in Table 1.
Inequality was analyzed by first describing geographical
differences in the incidence of cervical cancer and then
measuring the association between such health outcome and
its social determinants as an approach to hypothesize on
explanations to disparities. The estimation of the degree of
inequality was carried out for each of the three decades and it
was also analyzed by tumor behavior (in situ or invasive) with the
purpose of determining the existence of differences. Analyzing
results by tumor behavior is meaningful for understanding health
disparities because behavior is itself an indication of how timely
the cancer was diagnosed.
In the first phase of the analysis, a description of inequality was
made by using cartographic representations and by estimating
the Theil-T index for incidence of cervical cancer in Costa
Rica. Across three decades, the incidence of carcinoma in
situ has been heterogeneously distributed along the territory,
although in terms of territory extension the 1990s had
the greatest area of high in situ cases incidence rates
(Figure 1).
A distribution pattern is more evident when examining the
incidence of invasive cervical cancer, which has more clearly
concentrated in the country’s coastal and border areas along the
last 31 years (Figure 2).
Theil-T index values are estimated on a scale that ranges from
zero to 100%, where zero is perfect equality and 100% is perfect
inequality. As measured by the Theil-T index, inequality has
moved from 87 to 83% and from 85 to 83% for in situ and invasive
cervical cancer, respectively, along three decades (Figure 3). All
of these values over 80% are evidence of high inequality levels.
But in spite of this rather high level of inequality, two important
phenomena have taken place. On one hand, inequality of in situ
cervical cancer has decreased in the population younger than 40
(left hand side of Figure 3).
On the other hand, inequality in invasive cervical cancer has
increased in the older population aged 40 to 59, but especially
in the 50–59 age group (right hand side of Figure 3), where the
inequality increased 11% from the 1980s to the 1990s and reached
a total 14% increase during the 31 year period from 1980 to 2010
(Table 2). The increase in inequality observed for invasive cancer
in women aged 50–59 was greater than any decrease in inequality
observed in other age groups (Table 2).
Carcinoma in situ/Invasive Cervical Cancer Ratios (CIS/ICC)
are also presented as indicators of inequality. They have
the advantage of allowing a cartographic representation of
geographical areas where inequalities occur. In Costa Rica, the
CIS/ICC ratio averaged 1.46 from 1980 to 2010 (Table 1). Results
from this indicator were presented in maps with ratios divided
into three categories: < 1 in red color (mostly late detection), 1–
1.49 in white color (around national average ratio), and > 1.50 in
blue color (mostly early detection).
CIS/ICC shows a concentration of red geographical units in
border areas, these are areas of late detection for cervical cancer,
meaning that a majority of new cases are diagnosed in late stages
rather than in situ. This inequality concentrates to the North
where border is shared with Nicaragua, to the South where
Costa Rica shares a limit with Panama, and in some coast areas
(Figure 4).
In the second phase of the analysis, Poisson and spatial
regression models were estimated to measure the association
between incidence and its social determinants. This was done
as an exercise to generate hypotheses about the factors that may
explain the inequality found in the first phase of analysis.
Poisson regressions were modeled at the geographical
district level. Incidence for the 2000–2010 period was modeled
as a function of economic condition, geographical access
to healthcare facilities and sub-utilization of papanicolaou
screening, which were in turn proxy measures of the social
determinants of incidence.
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FIGURE 1 | Incidence of in situ cervical cancer, by time period. Costa Rica: 1980–2010 (Annualized rates per 100,000 women).
FIGURE 2 | Incidence of invasive cervical cancer, by time period. Costa Rica: 1980–2010 (Annualized rates per 100,000 women).
These Poisson regression analyses were conducted for total
incidence and they were also stratified by tumor behavior; that is,
for in situ and for invasive diagnosis. Incidence Rate Ratios (IRR)
were estimated. Sub-utilization of Papanicolaou was significantly
associated with a 36% decrease in the probability of early “in situ”
diagnosis (IRR= 0.637, p= 0.003) (Table 3).
Finally, geographic regression analyses were conducted for
invasive cervical cancer incidence. Same as with Poisson
models, this regression was estimated for the 2000–2010
period. The same set of independent variables that were
used in the previous models, was used for this spatial
regression model: economic condition, geographical access
to healthcare services and sub-utilization of Pap smear.
Standardized residuals resulting from this modeling are shown
in Figure 5. These residuals represent the difference between
the observed incidence of invasive cervical cancer and the
incidence that was predicted by the spatial regression equation.
Areas where the incidence was lower than expected are
represented in blue; areas where the incidence is approximately
the same as expected are represented in white and those
where the incidence is greater than expected are represented
in red.
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FIGURE 3 | Inequality in the incidence of cervical cancer, by tumor behavior and time period. Costa Rica: 1980–2010 (Theil-T Index, %).
TABLE 2 | Relative (%) change in inequality as measured by Theil-T index in the incidence of cervical cancer, by tumor behavior and period of change. Costa Rica:
1980–2010.
Age In situ Invasive
1980s−1990s 1990s−2000s 1980s−2000s 1980s−1990s 1990s−2000s 1980s−2000s
<30 −4.0 −4.2 −8.0 −0.5 −6.2 −6.6
30–39 1.7 −8.1 −6.6 0.2 −5.1 −4.9
40–49 2.6 −2.7 −0.2 1.6 1.8 3.4
50–59 −1.6 0.1 −1.5 10.7 2.9 13.9
60+ −10.0 0.5 −9.6 −4.0 −1.1 −5.0
Total −1.2 −3.7 −4.8 −0.2 −2.2 −2.4
DISCUSSION
In Costa Rica the Cervical Cancer Prevention Program was
created in 1960. Beginning the 1970s Papanicolaou screening
was increasingly taking part of sexual and reproductive programs
targeted to women 15 to 49 years of age. As a result,
Pap smear coverage had an important upsurge. In the early
1980s, the national coverage of at least one Pap smear during
lifetime was 51% for women aged 15–49, but it reached
70% in 1986 and 74% in 1993 (40–42). The geographical
pattern observed in the incidence of in situ cervical cancer
from the 1980s to the 1990s decade, when the greatest
territory extension of in situ high rates occurred, illustrates
the expansion of the screening program that has just been
described.
Nonetheless, as Theil-T index results showed, the most
relevant decrease in inequality occurred from the 1990s to the
2000s rather than from the 1980s to the 1990s. In 1995, a health
sector reform was initiated in lower socioeconomic regions of
the country, and it was progressively expanded to the entire
country. This reform implied a better allocation of resources
given the fact that instead of having two government institutions
providing services, the Social Security System was assigned to
offer healthcare services and the Ministry of Health was assigned
a directing role. Rosero-Bixby (43) showed that this reform had
an impact on reducing inequality in access to primary healthcare
services. Our study findings support Rosero-Bixby’s conclusion
of a decrease of inequality in cervical cancer incidence from the
1990s to the 2000s that is probably a result of the combination
of a well-established Cervical Cancer Prevention Program in
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FIGURE 4 | In situ/Invasive Cervical Cancer Incidence Ratios, by time period. Costa Rica: 1980–2010.
TABLE 3 | Incidence rate ratios from a Poisson regression model to explain the incidence of cervical cancer, by tumor behavior. Costa Rica: 2000–2010.
Independent variables In situ Invasive Total
IRR p IRR p IRR p
Economic condition 1.002 0.175 1.008 <0.001 1.004 <0.001
Geographic access to healthcare 1.001 <0.001 1.001 <0.001 1.001 <0.001
Pap sub-utilization 0.637 0.003 1.020 0.921 0.755 0.022
the context of a health sector reform. This inequality decrease
however, did not occur for all age groups and geographic areas
of the country.
Female population younger than 40 years experienced the
benefits of a national prevention program that was probably
more successful in screening women at reproductive age, than
it was in following-up and treating, especially after childbearing.
Inequality in cervical cancer showed a modest decrease in 31
years, a decrease that could have been more important had
older age groups received equal benefits that were received
by younger women. In this context, although it is known
that after the age of 40 the risk of cervical cancer decreases,
that is the age that signals inequality rises in Costa Rica.
Women aged 50 to 59 is the worst off group. The increase
in inequality in this group is greater than any gain in terms
of equality occurred in the rest of age groups along three
decades. These disadvantaged women belong to cohorts that,
in terms of age, either were part or soon became part of
the prevention program target population. In the 1960s the
prevention program started. Women aged 50 to 59 in the
1980s were around 30 back then. Those aged 50 to 59 in the
1990s were about 20 when the prevention program started. And
those aged 50 to 59 in the 2000s were around 10 years of
age. These cohorts probably experienced the advantages of the
prevention program in terms of screening, but also experienced
the disadvantages of lack of follow-up. Not only these cohorts
have not had a decrease in the in situ incidence inequality,
but also have had the most important inequality increase in
invasive cervical cancer, representing lost opportunities in cancer
prevention.
In terms of geographic inequality, coast areas have long been
described as the highest incidence regions the country. Between
1980 and 1983 Guanacaste and Puntarenas, both of them coast
provinces, were shown to have the highest incidence; and Limón,
another coast province, had the highest mortality. Unequal access
to screening in Limón, as well as sexual behavior patterns in
the coast were hypothesized as possible causes of geographic
inequality (42). Between 1986 and 1987, (44) conducted a
case-control study and concluded that the higher incidence of
cervical cancer in coastal vs. metropolitan areas could not be
attributed to differential access to Papanicolaou screening but to
differences in reproductive behavior among populations. They
observed these differences in age at first intercourse, number
of sexual partners, number of children, and history of sexually
transmitted infections, among others. (45) showed how Limón
is a province of high inequality in terms of cervical cancer,
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FIGURE 5 | Observed as compared to expected probability of invasive
cervical cancer incidence. Costa Rica: 2000–2010.
with the highest share of invasive as compared to in situ
incidence.
Our study findings regarding the geographical pattern of
invasive cervical cancer show again how coast areas continue
having the highest rates, as well as the lowest In situ/Invasive
Cervical Cancer Ratios along three decades. Given the lack
of population based data, testing an association between
sexual behavior differences (42, 44) and incidence rates was
not feasible in this study. However, an association between
screening sub-utilization and incidence was found. The fact
that after controlling for the effect of both economic condition
and geographical access to healthcare services, screening sub-
utilization is significantly associated with a lower probability of
early detection is an important finding.
Previous studies have also found an association between
cervical cancer incidence and low utilization rates of screening
(46, 47). It has been described that cultural and social values
are factors that influence access to cervical cancer screening
(48). Future research should address the reasons why in a
universal healthcare system such as the Costa Rican one,
women still do not adequately access Papanicolaou screening.
Geographical access according to our study can be ruled out,
but cultural aspects may be mediating decisions to access
screening services. This study results highlight finer tuned
places where more research should be conducted to explain an
incidence of invasive cervical cancer that exceeds what could be
predicted.
CONCLUSION
An unequal distribution of cervical cancer incidence has
been described around the world. Disparities resulting
from unnecessary, avoidable and unjust inequality occur
globally (49). Although cervical cancer mortality rates have
decreased over time, inequality has persisted in different
contexts all over the globe. Taken altogether this study
results provide evidence of inequality and highlight age
groups and geographical areas that merit special attention.
Inequality in the incidence of cervical cancer must be
avoided regardless of women’s age or place of residence.
Age groups where inequality has been increasing and areas
with a significantly higher than expected incidence of invasive
cervical cancer represent opportunities to target early detection
initiatives.
Most of cervical cancer cases may be detected with screening.
Timely access to preventive services facilitates the detection of
this neoplasm in early stages. Nevertheless, in general, low-
income women have higher detection rates in late stages (12).
In the United States, similar to what happens in Costa Rica and
other countries; incidence has significantly decreased since the
introduction of Papanicolaou screening. Nonetheless, even with
the existence of screening, disparities in the incidence of cervical
cancer persist in the US (50) as well as in other populations
such as Costa Rica where a universal healthcare system is in
place.
Cancer control and prevention are key to decrease inequality
(51, 52). Response to cervical cancer can be divided into
primary and secondary care. Focused on prevention, vaccination
constitutes an advisable primary care strategy. Over the years,
the use of the HPV vaccine has demonstrated to be an effective
way to prevent cervical cancer. Including the HPV vaccine in
the vaccination scheme has been previously suggested as a mean
to improve the effectiveness of the Cervical Cancer Prevention
Program in Costa Rica (45). Although the HPV vaccine is not
yet available for the entire population in Costa Rica, it has
recently been approved to be included in the social security
system’s vaccination scheme starting in 2019 in 10-year-old
girls.
Secondary care is based on two elements, early diagnosis,
and screening. Improving detection and offering opportune
treatment of diagnosed cases are necessary conditions to
alleviate the cervical cancer burden. Differences in Pap screening
procedures among regions within the country and long waiting
times between sampling and availability of laboratory results
have been previously described as critical points in the Cervical
Cancer Prevention Program in Costa Rica (53). Since the
1990s, human papillomavirus HPV-DNA testing has been
proposed for the detection of cervical cancer precursors, either
as a complement or as an alternative method to Pap smear.
Epidemiological studies in Costa Rica and other developing
countries have evidenced the effectiveness of HPV-DNA testing
(54–56). [Quirós (45)] has suggested the inclusion of HPV-DNA
testing in the Cervical Cancer Prevention Program in Costa Rica,
which may be of special interest in the context described in this
study.
Frontiers in Oncology | www.frontiersin.org 9 January 2019 | Volume 8 | Article 664
Santamaría-Ulloa and Valverde-Manzanares Inequality in Cervical Cancer
Once inequality exists, it can only decrease if actions are taken
toward such purpose. Policy aimed at specifically diminishing
inequality in cervical cancer incidence is warranted. Results from
this study identify regions of the country where actions may be
focused in order to reduce gaps in women’s health. Populations in
the coast and border regions of the country should be prioritized.
Integrated and inter-institutional approaches to education and
health promotion are recommended. Strategies to promote an
adequate use of screening with priority among women aged 50
to 59 years should be established in Costa Rica.
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